# UNIVERSITY OF CALIFORNIA LOS ANGELES: Regulated, Long-Term Expression of Anti-HIV Antibodies via B Cell Receptor-Targeted Lentiviral Transduction

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF CALIFORNIA LOS ANGELES |
| Location | LOS ANGELES, CA |
| Project | Regulated, Long-Term Expression of Anti-HIV Antibodies via B Cell Receptor-Targeted Lentiviral Transduction |
| Project number | 1R01AI200582-01A1 |
| Mechanism | R01 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $5,927,367 |
| Awarded | 2026-09-23 |
| Project period | 2026-09-23 to 2030-08-31 |
| UEI | RN64EPNH8JC6 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11537080). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.